A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

NCT03516123 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: CS3006

Sponsor

CStone Pharmaceuticals